Antibiotic prophylaxis in clean-contaminated head and neck oncological surgery

Journal of Cranio-Maxillofacial Surgery

Volumn 35, Issue 1, 2007, Pages 15-20

  SKITARELIĆ, Neven ^a   MOROVIĆ, Miro ^a   MANESTAR, Darko ^b  

^a GENERAL HOSPITAL ZADAR   (Croatia)

^b KBC RIJEKA   (Croatia)

Author keywords

antibiotics; clean contaminated surgery; oncology

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFAZOLIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENTEROCOLITIS; FEMALE; GRAM NEGATIVE BACTERIUM; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; URINARY TRACT INFECTION; WOUND INFECTION;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTIBIOTIC PROPHYLAXIS; BRONCHITIS; CARCINOMA, SQUAMOUS CELL; CEFAZOLIN; DOUBLE-BLIND METHOD; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRAVENOUS; LARYNGEAL NEOPLASMS; MOUTH NEOPLASMS; PHARYNGEAL NEOPLASMS; PNEUMONIA, BACTERIAL; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; TRACHEITIS;

EID: 33847151187     PISSN: 10105182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcms.2006.10.006     Document Type: Article

References (31)

1. Barie P.S. Importance, morbidity, and mortality of pneumonia in the surgical intensive care unit. Am J Surg 179 (2000) 2-7
2. Bodey G.P. Pseudomonas aeruginosa infections in cancer patients: have they gone away?. Curr Opin Infect Dis 14 (2001) 403-407
3. Bradford P.A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 14 (2001) 933-951
4. Callender D.L. Antibiotic prophylaxis in head and neck oncologic surgery: the role of Gram-negative coverage. Int J Antimicrob Agents 12 (1999) 21-25
5. Clayman G.L., Raad II., Hankins P.D., and Weber R.S. Bacteriologic profile of surgical infection after antibiotic prophylaxis. Head Neck 15 (1993) 526-531
6. Cole R.R., Robbins K.T., Cohen J.I., and Wolf P.F. A predictive model for wound sepsis in oncologic surgery of the head and neck. Otolaryngol Head Neck Surg 96 (1987) 165-171
7. Fabian T.C. Empiric therapy for pneumonia in the surgical intensive care unit. Am J Surg 179 (2000) 18-25
8. Fleming I.D., Cooper J.S., Henson D.E., Hutter R.V.P., Kennedy B.J., Murphy G.P., O'Sullivan B., Sobin L.H., and Yarbro J.W. AJCC Cancer Staging Handbook. 5th edition (1998), Lippincott-Raven, Philadelphia
9. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 16 (1988) 128-140
10. Girod D.A., McCulloch T.M., Tsue T.T., and Weymuller E.A. Risk factors for complications in clean-contaminated head and neck surgical procedures. Head Neck 17 (1995) 7-13
11. Johnson J.T., Yu V.L., Myers E.N., and Wagner R.L. An assessment of the need for Gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis 115 (1987) 331-333
12. Johnson J.T., Kachman K., Wagner R.L., and Myers E.N. Comparison of ampicillin/sulbactam versus clindamycin in the prevention of infection in patients undergoing head and neck surgery. Head Neck 19 (1997) 367-371
13. Kaiser A.B. Postoperative infections and antimicrobial prophylaxis. In: Mandell G.L., Douglas R.G., and Bennett J.E. (Eds). Principles and Practice of Infectious Diseases, 3rd edition (1990), Churchill Livingstone, New York 2245-2257
14. Khuri S.F., Daley J., Henderson W., Hur K., Gibbs J.O., Barbour G., Demakis J., Irvin III G., Stremple J.F., Grover F., McDonald G., Passaro Jr. E., Fabri P.J., Spencer J., Hammermeister K., and Aust J.B. Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 185 (1997) 315-327
15. McGuirt W.F., McCabe B.F., and Krause C.J. Complications of radical neck dissection: a survey of 788 patients. Head Neck Surg 1 (1979) 481-487
16. Mortimore S., and Thorp M. Cervical necrotizing fasciitis and radiotherapy: a report of two cases. J Laryngol Otol 112 (1998) 298-300
17. Muir C., and Weiland L. Upper aerodigestive tract cancers. Cancer 75 (1995) 147-153
18. Penel N., Lefebvre D., Fournier C., Sarini J., Kara A., and Lefebvre J.L. Risk factors for wound infection in head and neck cancer surgery: a prospective study. Head Neck 23 (2001) 447-455
19. Penel N., Fournier C., Roussel-Delvallez M., Lefebvre D., Kara A., Mallet Y., Neu J.C., and Lefebvre J.L. Prognostic significance of wound infections following major head and neck surgery: an open non-comparative prospective study. Support Care Cancer 12 (2004) 634-639
20. Robbins K.T., Byers R.M., Cole R., Fainstein V., Guillamondegui O.M., Schantz S.P., Weber R.S., Wolf P., and Goepfert H. Wound prophylaxis with metronidazole in head and neck surgical oncology. Laryngoscope 98 (1988) 803-806
21. Rodrigo J.P., Alvarez J.C., Gomez J.R., Suarez C., Fernandez J.A., and Martinez J.A. Comparison of three prophylactic antibiotic regimens in clean-contaminated head and neck surgery. Head Neck 19 (1997) 188-193
22. Rodrigo J.P., Surez C., Bernaldez R., and Collado D. The Piperacillin-Tazobactam Head and Neck Study Group. Efficacy of piperacillin-tazobactam in the treatment of surgical wound infection after clean-contaminated head and neck oncologic surgery. Head Neck 26 (2004) 823-828
23. Rosenfield R.M. Meta-analysis. Oto Rhino Laryngol 66 (2004) 186-195
24. Sabirana F.X., Lorente J., Perez M., Quesada J.L., Grasa J., Fortuny P., Rosello J., and Quesada P. Antibiotic prophylaxis in oncologic pharyngolaryngeal surgery: ceftriaxone versus clindamycin and gentamycin. Acta Otorrinolaringol Esp 52 (2001) 142-145
25. Schwaber M.J., Navon-Venezia S., Schwartz D., and Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 49 (2005) 2137-2139
26. Shinagawa N., Yamanaka N., Suzuki K., Kawauchi H., Oda M., Yajin K., Ishizuka Y., Kurono Y., Iwai S., Yokoyama T., and Takeyama H. A questionnaire survey on the theory of postoperative infection prophylaxis in otorhinolaryngology. Jpn J Antibiot 56 (2003) 15-26
27. Skitarelić N., Mladina R., Morović M., and Skitarelić N. Cervical necrotizing fasciitis: sources and outcomes. Infection 31 (2003) 39-44
28. Sweeney G., Watson J.D., McGregor I.A., and Sleigh H.D. Successful prophylaxis with tinidazole of infection after major head and neck surgery for malignant disease. Br J Plast Surg 37 (1984) 35-42
29. Weber R.S., and Callender D.L. Antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery. Ann Otol Rhinol Laryngol 101 (1992) 16-20
30. Weber R.S., Raad I., Frankenthaler R., Hankins P., Byers R.M., Guillamondegui O., Wolf P., Smith T., and Goepfert H. Ampicillin-sulbactam vs. clindamycin in head and neck oncologic surgery: the need for Gram-negative coverage. Arch Otolaryngol Head Neck Surg 118 (1992) 1159-1163
31. Weber R.S., Hankins P., Rosenbaum B., and Raad I. Nonwound infections following head and neck oncologic surgery. Laryngoscope 103 (1993) 22-27